As Joe Rogan told it, President Donald Trump jumped at the chance to facilitate regulatory approval of ibogaine and other ...

President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.

Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.

Psychedelic Science 2027 (PS27) convenes May 3–7, 2027, at the Colorado Convention Center in Denver under the theme “Bridging ...

Prior to the widespread use of medications like the EpiPen, Adderall, or Ozempic, the average person probably knew and thought very little about those now-popular drugs. Creating new medications can ...

Clinical trials prove the efficacy of psychedelic treatments. Dr. Itamar Cohen reveals the cold economic interest behind the ...

This story was published in the Fall 2023 issue of UC San Diego Magazine. The story of psychedelics research at UC San Diego does not begin with research scientist Albert Yu-Min Lin, but it is ...

Psychedelic medications, backed by the White House, may alter the prognosis for people with treatment-resistant depression, ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration: Joanna Andreasson Source images: iStock Rick Doblin had come to believe that psychedelic experiences are the "common ...

Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or ...

In a groundbreaking move, the U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among ...

As the field of mental health continues to evolve, psychedelic drugs are increasingly undergoing rigorous scientific research for their therapeutic potential. Molecules like psilocybin, MDMA, and DMT ...